BACKGROUND: Little is known about family members' interrelated decisions to seek genetic testing for breast cancer susceptibility. METHODS: The specific aims of this cross-sectional, descriptive, cohort study were (i) to examine whether individual and family characteristics have a direct effect on women's decisions to use genetic testing for hereditary susceptibility to breast cancer and (ii) to explore whether family characteristics moderate the relationships between individual characteristics and the decision to use genetic testing. Participants were women (>18 years old) who (i) received genetic testing for hereditary breast cancer and who agreed to invite one of their female relatives into the study and (ii) female relatives who had NOT obtained genetic testing and were identified by pedigree analysis as having >10% chances of hereditary susceptibility to breast cancer. RESULTS: The final sample consisted of 168 English-speaking, family dyads who completed self-administered, mailed surveys with validated instruments. Multivariate conditional logistic regression analyses showed that the proposed model explained 62% of the variance in genetic testing. The factors most significantly associated with genetic testing were having a personal history of cancer; perceiving genetic testing to have more benefits than barriers; having greater family hardiness; and perceiving fewer negative consequences associated with a breast cancer diagnosis. No significant interaction effects were observed. CONCLUSIONS: Findings suggest that both individual and family characteristics are associated with the decision to obtain genetic testing for hereditary breast cancer; hence, there is a need for interventions that foster a supportive family environment for patients and their high-risk relatives.
BACKGROUND: Little is known about family members' interrelated decisions to seek genetic testing for breast cancer susceptibility. METHODS: The specific aims of this cross-sectional, descriptive, cohort study were (i) to examine whether individual and family characteristics have a direct effect on women's decisions to use genetic testing for hereditary susceptibility to breast cancer and (ii) to explore whether family characteristics moderate the relationships between individual characteristics and the decision to use genetic testing. Participants were women (>18 years old) who (i) received genetic testing for hereditary breast cancer and who agreed to invite one of their female relatives into the study and (ii) female relatives who had NOT obtained genetic testing and were identified by pedigree analysis as having >10% chances of hereditary susceptibility to breast cancer. RESULTS: The final sample consisted of 168 English-speaking, family dyads who completed self-administered, mailed surveys with validated instruments. Multivariate conditional logistic regression analyses showed that the proposed model explained 62% of the variance in genetic testing. The factors most significantly associated with genetic testing were having a personal history of cancer; perceiving genetic testing to have more benefits than barriers; having greater family hardiness; and perceiving fewer negative consequences associated with a breast cancer diagnosis. No significant interaction effects were observed. CONCLUSIONS: Findings suggest that both individual and family characteristics are associated with the decision to obtain genetic testing for hereditary breast cancer; hence, there is a need for interventions that foster a supportive family environment for patients and their high-risk relatives.
Authors: Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban Journal: Cancer Date: 2016-07-22 Impact factor: 6.860
Authors: Marleah Dean; Ann L Tezak; Sabrina Johnson; Joy K Pierce; Anne Weidner; Kate Clouse; Tuya Pal; Deborah Cragun Journal: Patient Educ Couns Date: 2021-01-05
Authors: Maria C Katapodi; Valeria Viassolo; Maria Caiata-Zufferey; Christos Nikolaidis; Nicole Buerki; Karl Heinimann; Viola Heinzelmann-Schwarz; Olivia Pagani; Pierre O Chappuis; Rosmarie Bührer-Landolt; Rossella Graffeo; Henrik Csaba Horváth; Christian Kurzeder; Manuela Rabaglio; Michael Scharfe; Corinne Urech; Tobias E Erlanger; Nicole Probst-Hensch Journal: JMIR Res Protoc Date: 2017-09-20
Authors: Maria C Katapodi; Miyeon Jung; Ann M Schafenacker; Kara J Milliron; Kari E Mendelsohn-Victor; Sofia D Merajver; Laurel L Northouse Journal: JMIR Cancer Date: 2018-04-13
Authors: Maria C Katapodi; Katrina R Ellis; Franziska Schmidt; Christos Nikolaidis; Laurel L Northouse Journal: Cancer Med Date: 2018-09-05 Impact factor: 4.452
Authors: Lenny N Gallardo-Alvarado; María Teresa Tusié-Luna; María Isabel Tussié-Luna; José Díaz-Chávez; Yayoi X Segura; Enrique Bargallo-Rocha; Cynthia Villarreal; Luis A Herrera-Montalvo; Enrique M Herrera-Medina; David F Cantu-de Leon Journal: BMC Cancer Date: 2019-02-01 Impact factor: 4.430
Authors: Carla Pedrazzani; Chang Ming; Nicole Bürki; Maria Caiata-Zufferey; Pierre O Chappuis; Debra Duquette; Karl Heinimann; Viola Heinzelmann-Schwarz; Rossella Graffeo-Galbiati; Sofia D Merajver; Kara J Milliron; Christian Monnerat; Olivia Pagani; Manuela Rabaglio; Maria C Katapodi Journal: Cancers (Basel) Date: 2021-12-13 Impact factor: 6.639